1. Winn R, Kliot M, and Brem H (2009) Youmans Neurological Surgery., Fifth ed., Philadelphia.
2. Preston-Martin S, Davis F, and McKean-Cowdin R. (2001) Epidemiology of primary brain tumors., In Brain tumor immunotherapy. (Liau, L. M., D.P., B., T.F., C., and D.D., B., Eds.), pp 47-72, Human Press.
3. Okada, H., Attanucci, J., Giezeman-Smits, K. M., Brissette-Storkus, C., Fellows, W. K., Gambotto, A., et al. (2001). Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Cancer Research, 61, 2625–2631.
4. Schneider, T., Gerhards, R., Kirches, E., & Firsching, R. (2001). Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme. Journal of Neuro-oncology, 53, 39–46.
5. Plautz, G. E., Miller, D. W., Barnett, G. H., Stevens, G. H., Maffett, S., Kim, J., et al. (2000). T cell adoptive immunotherapy of newly diagnosed gliomas. Clinical Cancer Research, 6, 2209–2218.